First Affiliated Hospital Of Guangxi Medical University
Clinical trials sponsored by First Affiliated Hospital Of Guangxi Medical University, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Can a stem cell spray stop radiation mouth pain? Results expected Jun 2027 (estimated)
-
Experimental CAR-T therapy targets tough childhood leukemia
Disease control CancelledThis early-phase study tests a new treatment called CLL-1 CAR-T for children aged 3 to 18 with acute myeloid leukemia that has come back or not responded to standard therapy. Ten participants will receive an infusion of their own modified immune cells after chemotherapy. The main…
Early phase 1 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Aug 28, 2026 00:00 UTC
-
Immunotherapy-Chemo cocktail targets tough colon cancer before surgery
Disease control OngoingThis phase 2 trial is testing whether adding the immunotherapy drug tislelizumab to standard chemotherapy (oxaliplatin and capecitabine) before surgery can help shrink tumors in people with a specific type of locally advanced colon cancer called microsatellite stable (MSS). About…
Phase 2 • Sponsor: First Affiliated Hospital of Guangxi Medical University • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC